会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • 목시플록사신 수성 제형 및 이의 제조방법
    • 莫西菌素配方及其制备方法
    • KR1020120116100A
    • 2012-10-22
    • KR1020110033646
    • 2011-04-12
    • 씨제이헬스케어 주식회사
    • 이민경김은선최광도홍주용변상환고재경
    • A61K9/08A61K31/4745A61K31/437A61K31/4709
    • A61K47/02A61K9/08A61K31/4709A61K2121/00
    • PURPOSE: A molxifloxacin aqueous formulation and a method of manufacture thereof are provided to enhance quality, content uniformity and accuracy. CONSTITUTION: A manufacturing method of a molxifloxacin aqueous formulation includes a step of dissolving a molxifloxacin free base into base aqueous solution, acid aqueous solution or a mixed solution thereof. The base solution is NaCl aqueous solution. The NaCl aqueous solution is 0.4-1.2% NaCl aqueous solution. 0.05-0.5g of the molxifloxacin glass base is included based on 100ml of the NaCl aqueous solution. The molxifloxacin free base is manufactured by the following steps: melting molxifloxacin acid salt in water extracting the molxifloxacin free base using organic solvent which does not mix with water; and re-crystallizing the molxifloxacin free base by putting an organic solvent which mixes with water.
    • 目的:提供莫西沙星含水制剂及其制备方法以提高质量,含量均匀性和准确性。 构成:莫西沙星含水制剂的制造方法包括将摩尔沙星游离碱溶解于碱性水溶液,酸性水溶液或其混合溶液中的步骤。 碱溶液为NaCl水溶液。 NaCl水溶液为0.4-1.2%NaCl水溶液。 基于100ml的NaCl水溶液含有0.05-0.5g的摩尔沙星玻璃碱。 通过以下步骤制备莫西沙星游离碱:使水不与水混合的有机溶剂在水中溶解摩尔沙星酸盐, 并通过将与水混合的有机溶剂重新结晶游离的莫西沙星。